An Open Label Prostate Cancer Study in Japanese Patients

Study identifier:D3760C00003

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD3514 in Japanese Patients with Metastatic Castration-Resistant Prostate Cancer

Medical condition

prostate cancer

Phase

Phase 1

Healthy volunteers

No

Study drug

AZD3514

Sex

Male

Actual Enrollment

16

Study type

Interventional

Age

20 Years - 150 Years

Date

Study Start Date: 01 Aug 2011
Primary Completion Date: 01 Mar 2013
Study Completion Date: 01 May 2013

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 May 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria